Introducing the Inspire Sleep Apnea Implant:
Say Goodbye to the CPAP Mask
Obstructive Sleep Apnea (OSA) affects 18 million Americans. It occurs when the airway collapses during sleep and blocks the flow of oxygen to the brain. The brain senses a lack of oxygen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats throughout the night and causes poor, disruptive sleep. When left untreated, OSA can cause vehicle and workplace accidents, worsening mood and memory, stroke, heart attack, and even death.
What is Inspire Sleep Apnea therapy?
Dr. Doug Anderson now offers a new surgical solution for obstructive sleep apnea called Inspire. Inspire therapy in Ogden works inside your body with your natural breathing process to treat sleep apnea through hypoglossal nerve stimulator implantation. Mild stimulation keeps the airway open during sleep, allowing air to flow naturally. A patient uses a small handheld remote to turn Inspire on before bed and off when they wake up. No mask, no noise, no hose.
How is the Inspire Sleep Apnea device implanted?
The Inspire sleep implant system at Ogden Clinic is placed under the skin of the neck and chest through three small incisions during an outpatient procedure. Most sleep apnea surgery patients return home the same day and take over-the-counter pain medications as needed.
Inspire Sleep Apnea Safety and Clinical Results
The safety and efficacy of Inspire hypoglossal nerve stimulator therapy was measured during the STAR clinical trial. One-year STAR trial results were published in January 9th, 2014 edition of the New England Journal of Medicine, showing patients using Inspire therapy had significant reductions in sleep apnea events and significant improvements in quality of life measures. These significant reductions and improvements were sustained over a 5-year follow-up period.
As of May 2018, there have been over 50 peer-reviewed publications on Inspire sleep implant therapy. These publications show sleep apnea surgery patients using Inspire therapy in real world, clinical practice settings experience significant reductions in sleep apnea events and significant improvements in quality of life measures, consistent with those seen in the STAR clinical trial.